Abstract:Electrical properties of cells determine most of the cellular functions, particularly ones which occur in the cell's membrane. Manipulation of these electrical properties may provide a powerful electrotherapy option for the treatment of cancer as cancerous cells have been shown to be more electronegative than normal proliferating cells. Previously, we used an electrical impedance sensing system (EIS) to explore the responses of cancerous SKOV3 cells and normal HUVEC cells to low intensity (<2 V/cm) AC electric fields, determining that the optimal frequency for SKOV3 proliferation arrest was 200 kHz, without harming the non-cancerous HUVECs. In this study, to determine if these effects are cell type dependant, human breast adenocarcinoma cells (MCF7) were subjected to a range of frequencies (50 kHz-2 MHz) similar to the previously tested SKOV3. For the MCF7, an optimal frequency of 100 kHz was determined using the EIS, indicating a higher sensitivity towards the applied field. Further experiments specifically targeting the two types of cancer cells using HER2 antibody functionalized gold nanoparticles (HER2-AuNPs) were performed to determine if enhanced electric field strength can be induced via the application of nanoparticles, consequently leading to the killing of the cancerous cells without affecting non cancerous HUVECs and MCF10a providing a platform for the development of a non-invasive cancer treatment without any harmful side effects. The EIS was used to monitor the real-time consequences on cellular viability and a noticeable decrease in the growth profile of the MCF7 was observed with the application of the HER2-AuNPs and the electric fields indicating specific inhibitory effects on dividing cells in culture. To further understand the effects of the externally applied field to the cells, an Annexin V/EthD-III assay was performed to determine the cell death mechanism indicating apoptosis. The zeta potential of the SKOV3 and the MCF7 before and after incorporation of the HER2-AuNPs was also obtained indicating a decrease in zeta potential with the incorporation of the nanoparticles. The outcome of this research will improve our fundamental understanding of the behavior of cancer cells and define optimal parameters of electrotherapy for clinical and drug delivery applications.

Platinum Nanoparticles to Enable Electrodynamic Therapy for Effective Cancer Treatment.

Platinum-copper alloy nanoparticles armored with chloride ion transporter to promote electro-driven tumor inhibition

Fe3O4@Pt Nanoparticles to Enable Combinational Electrodynamic/chemodynamic Therapy

Mesoporous Silica Decorated with Platinum Nanoparticles for Drug Delivery and Synergistic Electrodynamic-Chemotherapy

Polyoxometalate Modified by Zeolite Imidazole Framework for the Ph-Responsive Electrodynamic/Chemodynamic Therapy

KCl-CaCO3 nanoclusters armoured with Pt nanocrystals for enhanced electro-driven tumor inhibition

Reaction Mechanisms in Platinum‐Mediated Electrodynamic Therapy

Electrodynamic Therapy: Novel Nanodynamic Strategy for Anticancer and Anti-Infection Therapy

Porous Pt nanoparticles loaded with doxorubicin to enable synergistic Chemo-/Electrodynamic Therapy

Copper-based inorganic nanozyme enhances the electrical conductivity of tumors to synergistically induce the pyroptosis, ferroptosis, and apoptosis of tumor

Noninvasive remote-controlled nanomedicine by using electric field stimulation for in vivo effective cancer therapy

Self‐Driven Electric Field Control of Orbital Electrons in AuPd Alloy Nanoparticles for Cancer Catalytic Therapy

Immuno nanoparticles integrated electrical control of targeted cancer cell development using whole cell bioelectronic device

[Progress in Electrochemotherapy].

Amorphous Liquid Metal Electrodes Enabled Conformable Electrochemical Therapy of Tumors.

Electrically activated polymetallic nanocrystals for long-term tumor suppression via oxygen-independent ROS generation and electro-immunotherapy

Electrochemical therapy (EChT) of cancer tumor with an external anode, a way to achieve pathological complete response

Platinum Based Theranostics Nanoplatforms for Antitumor Applications.

Blood-triggered Generation of Platinum Nanoparticle Functions As an Anti-Cancer Agent

Nanogalvanic Cells Release Highly Reactive Electrons in Tumors to Effectively Eliminate Tumors

Magneto‐Electrically Enhanced Intracellular Catalysis of FePt‐FeC Heterostructures for Chemodynamic Therapy